{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-23-000103","form_type":"8-K/A","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.567757+00:00","generated_at":"2026-06-20T02:04:12.494541+00:00","sec_items":["9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Lipella amends 8-K to correct investor presentation; no new business details","bullets":["Amendment corrects earlier 8-K that mistakenly included an earlier version of the investor presentation.","Corrected presentation (Exhibit 99.1) includes additional slides not in the original filing.","No financial or operational updates disclosed in this amendment; presentation content not excerpted."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-23-000103","json":"https://secwatch.observer/filing/0001753926-23-000103.json","markdown":"https://secwatch.observer/filing/0001753926-23-000103.md","text":"https://secwatch.observer/filing/0001753926-23-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623000103/0001753926-23-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392623000103/g083377_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T02:04:12.494541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}